159 related articles for article (PubMed ID: 32719245)
1. Genetic and proteomic biomarkers of head-and-neck cancer: A systematic review.
Kasradze D; Juodzbalys G; Guobis Z; Gervickas A; Cicciù M
J Cancer Res Ther; 2020; 16(3):410-424. PubMed ID: 32719245
[TBL] [Abstract][Full Text] [Related]
2. Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.
Juodzbalys G; Kasradze D; Cicciù M; Sudeikis A; Banys L; Galindo-Moreno P; Guobis Z
Cancer Biomark; 2016; 17(4):487-502. PubMed ID: 27802200
[TBL] [Abstract][Full Text] [Related]
3. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs in head and neck cancer.
Li X; Cao Y; Gong X; Li H
Oncotarget; 2017 Feb; 8(6):10726-10740. PubMed ID: 27802187
[TBL] [Abstract][Full Text] [Related]
5. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours.
Cossu AM; Mosca L; Zappavigna S; Misso G; Bocchetti M; De Micco F; Quagliuolo L; Porcelli M; Caraglia M; Boccellino M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336999
[TBL] [Abstract][Full Text] [Related]
8. Head and Neck Cancer in Saudi Arabia: a Systematic Review.
Alhazzazi TY; Alghamdi FT
Asian Pac J Cancer Prev; 2016; 17(8):4043-8. PubMed ID: 27644659
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
Hoxhaj I; Vukovic V; Boccia S; Pastorino R
BMC Cancer; 2021 Jun; 21(1):660. PubMed ID: 34078296
[TBL] [Abstract][Full Text] [Related]
10. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
11. mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis.
Marques AE; Elias ST; Porporatti AL; Castilho RM; Squarize CH; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2016 May; 45(5):319-28. PubMed ID: 26661562
[TBL] [Abstract][Full Text] [Related]
12. Analysis of gene co‑expression network reveals prognostic significance of CNFN in patients with head and neck cancer.
Liu B; Huang G; Zhu H; Ma Z; Tian X; Yin L; Gao X; He X
Oncol Rep; 2019 Apr; 41(4):2168-2180. PubMed ID: 30816522
[TBL] [Abstract][Full Text] [Related]
13. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
[TBL] [Abstract][Full Text] [Related]
14. Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol.
Shaw P; Raymond G; Senthilnathan R; Kumarasamy C; Baxi S; Suresh D; Shetty S; Ram M R; Chandramoorthy HC; Sivanandy P; Samiappan S; Rajagopal M; Krishnan S; Jayaraj R
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946979
[No Abstract] [Full Text] [Related]
15. Increased expression of ERCC2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study.
Zafeer M; Mahjabeen I; Kayani MA
Int J Biol Markers; 2016 Feb; 31(1):e17-25. PubMed ID: 26659720
[TBL] [Abstract][Full Text] [Related]
16. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer.
Chiu CC; Lin CY; Lee LY; Chen YJ; Lu YC; Wang HM; Liao CT; Chang JT; Cheng AJ
Clin Cancer Res; 2011 Jul; 17(14):4629-41. PubMed ID: 21642380
[TBL] [Abstract][Full Text] [Related]
17. Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Silva FFVE; Padín-Iruegas ME; Caponio VCA; Lorenzo-Pouso AI; Saavedra-Nieves P; Chamorro-Petronacci CM; Suaréz-Peñaranda J; Pérez-Sayáns M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233242
[TBL] [Abstract][Full Text] [Related]
18. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.
Tyszkiewicz T; Jarzab M; Szymczyk C; Kowal M; Krajewska J; Jaworska M; Fraczek M; Krajewska A; Hadas E; Swierniak M; Markowski J; Lange D; Poltorak S; Wiench M; Krecicki T; Jarzab J; Maciejewski A
Folia Histochem Cytobiol; 2014; 52(2):79-89. PubMed ID: 25007175
[TBL] [Abstract][Full Text] [Related]
19. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
20. The molecular markers of cancer stem cells in head and neck tumors.
Yu SS; Cirillo N
J Cell Physiol; 2020 Jan; 235(1):65-73. PubMed ID: 31206697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
